uniQure to Announce Third Quarter 2026 Financial Results
Key Highlights
- ➤uniQure will report Q3 2026 financial results before market open November 4
- ➤Management will host an earnings conference call at 8:30 a.m. ET
- ➤uniQure advances gene therapies for Huntington's disease and other severe diseases
LEXINGTON, Mass. and AMSTERDAM, Oct. 28, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report third quarter 2026 financial results before market open on Wednesday, November 4, 2026. Management will then host a conference call at 8:30 a.m. ET.
The event will be webcast under the Events & Presentations section of uniQure’s website at https://www.uniqure.com/investors-media/events-presentations, and following the event a replay will be archived for 90 days. Analysts wishing to participate in the question and answer session should access the live call by dialing (646) 307-1963 or toll-free (800) 715-9871 and entering conference ID 5075555. If you are joining the conference call, please join 15 minutes before the start time.
Get started
Create a free account to read the full story.